a day ago
IRON
AnalystsDanielle BrillDanielle Brill's Stock Forecasts
AnalystsDanielle Brill
Analyst Ranking
Top 16%
#842 out of 5545 analysts
Average Return
+9.16%
Win Rate
43%53 out of 122
Risk vs Reward
Poor
Good
Danielle Brill's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +1,074.35% | $5.42 | $63.65 | 2024-10-10 - 2025-10-09 | Buy |
Palvella Therapeutics IncPVLA | +300.48% | $31.00 | $124.15 | 2025-07-21 - 2026-07-20 | Strong Buy |
Centessa Pharmaceuticals PLCCNTA | +152.18% | $16.06 | $40.50 | 2025-07-21 - 2026-06-26 | Strong Buy |
Sage Therapeutics IncSAGE | +149.76% | $70.20 | $175.33 | 2017-05-16 - 2018-05-16 | Buy |
Dianthus Therapeutics IncDNTH | +118.26% | $35.55 | $77.58 | 2025-10-14 - 2026-10-13 | Strong Buy |
Danielle Brill Analyst Color
Get additional color on Danielle Brill's coverage of popular stocks
2 months ago
SLDB
2 months ago
ARGX
2 months ago
JCAP
2 months ago
BBIO
2 months ago
INSM
2 months ago
DNTH
3 months ago
NBIX
5 months ago
RAPP
5 months ago
PRAX
5 months ago
NBIX
6 months ago
BBIO
7 months ago
DNTH
8 months ago
BBIO
8 months ago
NBIX
9 months ago
CNTA
9 months ago
ARGX
9 months ago
NBIX
9 months ago
DNTH
9 months ago
CNTA
9 months ago
BBIO
10 months ago
PVLA
a year ago
IRON
a year ago
BBIO
a year ago
ALNY
Danielle Brill's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Disc Medicine IncIRON | 8 | Strong Buy | $115.00 | +44.69% | Maintains | a day ago |
Solid Biosciences IncSLDB | 1 | Strong Buy | $20.00 | +212.50% | Maintains | 2 months ago |
Argenx SeARGX | 9 | Strong Buy | $1,095.00 | +25.90% | Maintains | 2 months ago |
Jefferson Capital IncJCAP | 2 | Strong Buy | $30.00 | +44.58% | Maintains | 2 months ago |
Apogee Therapeutics IncAPGE | 3 | Hold | $135.00 | -0.05% | Maintains | 2 months ago |
Upstream Bio IncUPB | 2 | Strong Buy | $25.00 | +786.52% | Maintains | 2 months ago |
Bridgebio Pharma IncBBIO | 6 | Strong Buy | $107.00 | +58.40% | Maintains | 2 months ago |
Insmed IncINSM | 2 | Strong Buy | $195.00 | +103.83% | Reiterates | 2 months ago |
Climb Bio IncCLYM | 2 | Strong Buy | $25.00 | +131.48% | Maintains | 2 months ago |
Dianthus Therapeutics IncDNTH | 4 | Strong Buy | $128.00 | +62.54% | Maintains | 2 months ago |
Harmony Biosciences Holdings IncHRMY | 11 | Hold | $34.00 | -12.14% | Maintains | 3 months ago |
Vertex Pharmaceuticals IncVRTX | 5 | Strong Buy | $565.00 | +9.78% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 6 | Strong Buy | $315.00 | +36.54% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 12 | Strong Buy | $213.00 | +50.00% | Maintains | 3 months ago |
Biogen IncBIIB | 3 | Strong Buy | $235.00 | -3.33% | Upgrades | 3 months ago |
Praxis Precision Medicines IncPRAX | 2 | Strong Buy | $616.00 | +132.90% | Maintains | 5 months ago |
Immunovant IncIMVT | 7 | Hold | $30.00 | +4.93% | Maintains | 5 months ago |
Rapport Therapeutics IncRAPP | 1 | Strong Buy | $56.00 | +90.67% | Assumes | 5 months ago |
Wave Life Sciences IncWVE | 1 | Strong Buy | $15.00 | +338.60% | Maintains | 6 months ago |
Maze Therapeutics IncMAZE | 2 | Strong Buy | $64.00 | +97.23% | Maintains | 6 months ago |
Centessa Pharmaceuticals PLCCNTA | 3 | Strong Buy | $38.00 | -6.17% | Maintains | 9 months ago |
Tectonic Therapeutic IncTECX | 3 | Strong Buy | $60.00 | +174.91% | Maintains | 9 months ago |
Palvella Therapeutics IncPVLA | 4 | Strong Buy | $190.00 | +53.32% | Maintains | 10 months ago |
Uniqure NvQURE | 6 | Strong Buy | $52.00 | N/A | Upgrades | 2 years ago |
Denali Therapeutics IncDNLI | 1 | Hold | N/A | N/A | Reinstates | 2 years ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $79.00 | N/A | Reinstates | 2 years ago |
Regenxbio IncRGNX | 1 | Buy | $18.00 | N/A | Reinstates | 2 years ago |
Sarepta Therapeutics IncSRPT | 3 | Buy | $150.00 | N/A | Reinstates | 2 years ago |
Sage Therapeutics IncSAGE | 2 | Hold | N/A | N/A | Reinstates | 2 years ago |
Acadia Pharmaceuticals IncACAD | 3 | Hold | N/A | N/A | Reinstates | 2 years ago |
Xenon Pharmaceuticals IncXENE | 2 | Buy | $50.00 | N/A | Reinstates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 2 | Buy | $51.00 | N/A | Reinstates | 2 years ago |
Passage Bio IncPASG | 5 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Ptc Therapeutics IncPTCT | 8 | Sell | N/A | N/A | Downgrades | 3 years ago |
Kyntra Bio IncKYNB | 2 | Buy | $875.00 | N/A | Upgrades | 4 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | N/A | N/A | Downgrades | 5 years ago |
Global Blood Therapeutics IncGBT | 4 | Hold | $50.00 | N/A | Downgrades | 6 years ago |
Gw Pharmaceuticals PLCGWPH | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Zogenix IncZGNX | 1 | Hold | N/A | N/A | Initiates Coverage On | 6 years ago |
Alder Biopharmaceuticals IncALDR | 2 | Buy | $28.00 | N/A | Assumes | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.